3 results
Approved WMOCompleted
The objective of the trial is to assess the long-term safety and tolerability of intracerebroventricular administration of sNN0029 infusion solution at a dose of 4 µg/day delivered via a Medtronic SynchroMed® II Infusion System.
Approved WMORecruiting
To assess the efficacy and safety of LCI699 in CD patients
Approved WMOWill not start
The objective of this study is to assess the safety and feasibility of WATS for esophageal sampling after nCRT in patient with esophageal cancer.